NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Not sure about all the rest, but the key point is that Huewei has the wherewithal to commercialize quickly in China. That alone makes NWBO a more valuable investment to Huewei than perhaps others potential buyers. Also, the proximity to AZN at Sawston could have evolved into a partnership between AZN and Huewei, which gives Huewei a strategic BP with expertise and access to global markets.

https://www.scmp.com/business/global-economy/article/2142351/chinese-funds-pour-us14b-us-biotechnology-firms-first-three

And....most importantly, Huawei would use the chinese brain cancer market as its launching pad. It really does not need to depend upon world markets. It could easily obtain chinese regulatory approvals and rapidly penetrate the market which is perhaps larger than all other world markets combined. It could also obtain reg approvals for other solid tumour indications.